(Drugs for Neglected Diseases Initiative) The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. (TSE: 4523) (‘Eisai’) and Takeda Pharmaceutical Company Limited (TSE: 4502) (‘Takeda’) have signed an agreement for GARDP to access and screen components of Eisai and Takeda’s chemical libraries.